Ven Bio Partners LLC Precision Biosciences Inc Transaction History

Ven Bio Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $7.76 Million - $16.2 Million	-1,298,191 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.65 - $8.73 $6.94 Million - $13 Million	-1,493,387 Reduced 53.5%	1,298,191 $8 Million
Q2 2020 Aug 14, 2020	SELL	$4.66 - $8.7 $5.67 Million - $10.6 Million	-1,216,323 Reduced 30.35%	2,791,578 $23.3 Million
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $1.3 Million - $3.86 Million	-257,240 Reduced 6.03%	4,007,901 $24.2 Million
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $74.4 Million - $76.6 Million	4,265,141 New	4,265,141 $68.6 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Ven Bio Partners LLC with notifications on news.